Evidence map›Paper›PMID 40765801›Full record

ArticleNagoya journal of medical science2025

High-dose-rate surface mold with tumor translucency brachytherapy for a 103-year-old patient with skin cancer, dementia, tremor, and kyphosis: a case report.

Masataka Nakai, Ken Yoshida, Tadayuki Kotsuma, Yuji Takaoka, Hironori Akiyama, Kentaro Ozawa, Eiichi Tanaka

Abstract readCase Reports
In one paragraph

Article in Nagoya journal of medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Masataka NakaiDepartment of Radiation Oncology, NHO Osaka National Hospital, Osaka, Japan.
Ken YoshidaDepartment of Radiation Oncology, NHO Osaka National Hospital, Osaka, Japan.
Tadayuki KotsumaDepartment of Radiation Oncology, NHO Osaka National Hospital, Osaka, Japan.
Yuji TakaokaDepartment of Radiation Oncology, NHO Osaka National Hospital, Osaka, Japan.
Hironori AkiyamaDepartment of Radiation Oncology, NHO Osaka National Hospital, Osaka, Japan.
Kentaro OzawaDepartment of Dermatology, NHO Osaka National Hospital, Osaka, Japan.
Eiichi TanakaDepartment of Radiation Oncology, NHO Osaka National Hospital, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer treatment for centenarians can be challenging. High-dose-rate surface mold brachytherapy is a non-invasive, radical treatment modality for surface cancer. Further, it is used for patients who cannot remain at rest or have poor posture. We performed this treatment on a 103-year-old female patient with forehead skin cancer, dementia, tremors, and kyphosis since radical surgery and external beam radiotherapy were not feasible. A custom-made surface mold with tube applicators was developed with vinyl sheet and silicone. The vinyl sheet was utilized to enable tumor visualization through the mold and to confirm the tumor position relative to the mold. The mold with tumor translucency was fixed to the tumor surface, and the radioisotope (Ir-193) was sent remotely through tube applicators for irradiation. The planning-aim doses were 48 Gy in eight fractions. The positional relationship between the mold and the tumor was confirmed similarly during irradiation by checking them through the vinyl sheet before and after irradiation. We treated the patient, although she was in constant motion during irradiation. The local tumor was well-controlled without any metastatic disease evidence. The tumor disappeared before her eventual death 11 months post-treatment. No serious adverse events were reported during the follow-up period. Our results indicate that high-dose-rate surface mold with tumor translucency brachytherapy is an effective cancer treatment for centenarians with dementia, tremors, and kyphosis.

Indexed as

BrachytherapyDementiaKyphosisSkin NeoplasmsTremorAged, 80 and overFemaleHumanscentenarianhigh-dose-rateskin cancersurface mold brachytherapy

Identifiers

PMID40765801
PMCPMC12320356

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.